Evidence map›Paper›PMID 24740065›Full record

ArticleNature2014

Domains of genome-wide gene expression dysregulation in Down's syndrome.

Audrey Letourneau, Federico A Santoni, Ximena Bonilla, M Reza Sailani, David Gonzalez, Jop Kind, Claire Chevalier, Robert Thurman, Richard S Sandstrom, Youssef Hibaoui and 18 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Nature, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 198 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
198citing papers in PubMed, 1 pooled it
52.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

198 citing papers in PubMed, 1 synthesis or guideline pooled it, 327 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Role of cystathionine-β-synthase and hydrogen sulfide in down syndrome.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Single-nucleus analysis reveals oxidative stress in Down syndrome basal forebrain neurons at birth.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  19. Article
  20. Article

138 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors at 9 institutions in 5 countries.

Audrey Letourneau1] Department of Genetic Medicine and Development, University of Geneva Medical School, University Hospitals of Geneva, 1211 Geneva, Switzerland [2].
Federico A Santoni1] Department of Genetic Medicine and Development, University of Geneva Medical School, University Hospitals of Geneva, 1211 Geneva, Switzerland [2].
Ximena BonillaDepartment of Genetic Medicine and Development, University of Geneva Medical School, University Hospitals of Geneva, 1211 Geneva, Switzerland.
M Reza SailaniDepartment of Genetic Medicine and Development, University of Geneva Medical School, University Hospitals of Geneva, 1211 Geneva, Switzerland.
David GonzalezCenter for Genomic Regulation, University Pompeu Fabra, 08003 Barcelona, Spain.
Jop KindDivision of Gene Regulation, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Claire ChevalierAneuPath 21, Institut de Génétique Biologie Moléculaire et Cellulaire, Translational medicine and Neuroscience program, IGBMC, ICS, PHENOMIN, CNRS, INSERM, Université de Strasbourg, UMR7104, UMR964, 1 rue Laurent Fries, 67404 Illkirch, France.
Robert ThurmanDepartment of Genome Sciences, University of Washington, Seattle, Washington 98195, USA.
Richard S SandstromDepartment of Genome Sciences, University of Washington, Seattle, Washington 98195, USA.
Youssef HibaouiStem Cell Research Laboratory, Department of Obstetrics and Gynecology, Geneva University Hospitals, 1211 Geneva, Switzerland.
Marco GarieriDepartment of Genetic Medicine and Development, University of Geneva Medical School, University Hospitals of Geneva, 1211 Geneva, Switzerland.
Konstantin PopadinDepartment of Genetic Medicine and Development, University of Geneva Medical School, University Hospitals of Geneva, 1211 Geneva, Switzerland.
Emilie FalconnetDepartment of Genetic Medicine and Development, University of Geneva Medical School, University Hospitals of Geneva, 1211 Geneva, Switzerland.
Maryline GagnebinDepartment of Genetic Medicine and Development, University of Geneva Medical School, University Hospitals of Geneva, 1211 Geneva, Switzerland.
Corinne GehrigDepartment of Genetic Medicine and Development, University of Geneva Medical School, University Hospitals of Geneva, 1211 Geneva, Switzerland.
Anne VannierDepartment of Genetic Medicine and Development, University of Geneva Medical School, University Hospitals of Geneva, 1211 Geneva, Switzerland.
Michel GuipponiDepartment of Genetic Medicine and Development, University of Geneva Medical School, University Hospitals of Geneva, 1211 Geneva, Switzerland.
Laurent FarinelliFASTERIS SA, 1228 Plan-les-Ouates, Switzerland.
Daniel RobyrDepartment of Genetic Medicine and Development, University of Geneva Medical School, University Hospitals of Geneva, 1211 Geneva, Switzerland.
Eugenia Migliavacca1] Department of Genetic Medicine and Development, University of Geneva Medical School, University Hospitals of Geneva, 1211 Geneva, Switzerland [2] Swiss Institute of Bioinfomatics, 1211 Geneva, Switzerland.
Christelle BorelDepartment of Genetic Medicine and Development, University of Geneva Medical School, University Hospitals of Geneva, 1211 Geneva, Switzerland.
Samuel DeutschDOE Joint Genome Institute, Walnut Creek, California 94598, USA.
Anis FekiStem Cell Research Laboratory, Department of Obstetrics and Gynecology, Geneva University Hospitals, 1211 Geneva, Switzerland.
John A StamatoyannopoulosDepartment of Genome Sciences, University of Washington, Seattle, Washington 98195, USA.
Yann HeraultAneuPath 21, Institut de Génétique Biologie Moléculaire et Cellulaire, Translational medicine and Neuroscience program, IGBMC, ICS, PHENOMIN, CNRS, INSERM, Université de Strasbourg, UMR7104, UMR964, 1 rue Laurent Fries, 67404 Illkirch, France.
Bas van SteenselDivision of Gene Regulation, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Roderic GuigoCenter for Genomic Regulation, University Pompeu Fabra, 08003 Barcelona, Spain.
Stylianos E Antonarakis1] Department of Genetic Medicine and Development, University of Geneva Medical School, University Hospitals of Geneva, 1211 Geneva, Switzerland [2] iGE3 Institute of Genetics and Genomics of Geneva, 1211 Geneva, Switzerland.
University of Geneva · CHUniversity of Washington · USPompeu Fabra University · ESUniversité de Strasbourg · FRUniversity Hospital of Geneva · CHJoint Genome Institute · USL.A.C. (Switzerland) · CHOncode Institute · NLThe Netherlands Cancer Institute · NL

Funding

A Comprehensive Catalog of Dnasel Hypersensitive SitesU54HG007010 · NHGRI · UNIVERSITY OF WASHINGTON · PI STAMATOYANNOPOULOS, JOHN A · 2012 to 2016
$12.4M
NHGRI NIH HHS U54 HG007010NHGRI NIH HHS U54HG007010
6 · The paper itself

Abstract

Trisomy 21 is the most frequent genetic cause of cognitive impairment. To assess the perturbations of gene expression in trisomy 21, and to eliminate the noise of genomic variability, we studied the transcriptome of fetal fibroblasts from a pair of monozygotic twins discordant for trisomy 21. Here we show that the differential expression between the twins is organized in domains along all chromosomes that are either upregulated or downregulated. These gene expression dysregulation domains (GEDDs) can be defined by the expression level of their gene content, and are well conserved in induced pluripotent stem cells derived from the twins' fibroblasts. Comparison of the transcriptome of the Ts65Dn mouse model of Down's syndrome and normal littermate mouse fibroblasts also showed GEDDs along the mouse chromosomes that were syntenic in human. The GEDDs correlate with the lamina-associated (LADs) and replication domains of mammalian cells. The overall position of LADs was not altered in trisomic cells; however, the H3K4me3 profile of the trisomic fibroblasts was modified and accurately followed the GEDD pattern. These results indicate that the nuclear compartments of trisomic cells undergo modifications of the chromatin environment influencing the overall transcriptome, and that GEDDs may therefore contribute to some trisomy 21 phenotypes.

Indexed as

AnimalsCells, CulturedChromatinChromosomes, Human, Pair 21Chromosomes, MammalianDNA Replication TimingDown SyndromeFemaleFetusFibroblastsGene Expression RegulationGenomeHistonesHumansInduced Pluripotent Stem CellsLysineChromatinHistonesLysine

Identifiers

PMID24740065
OpenAlexW2077252523

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.